Back to School: How biopharma can reboot drug development. Access exclusive analysis here

First-day bump for Autolus after pricing $150M IPO

Autolus Therapeutics plc (NASDAQ:AUTL) climbed $8 (47%) to $25 its first day

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE